NCT06499818Not yet recruiting
CPVI Alone Versus CPVI Plus Low-Voltage Areas Ablation During SR Versus CPVI Plus Low-Voltage Areas Ablation During AF for the Treatment of CAF
Circumferential Pulmonary Vein Isolation Alone Versus CPVI Plus Low-Voltage Areas Ablation During SR Versus CPVI Plus Low-Voltage Areas Ablation During AF for the Treatment of CAF
Source: ClinicalTrials.gov · Last updated 15 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary objective of this investigation is to compare the efficacy of Three different AF ablation strategies in patients with Persistent atrial fibrillation: CPVI plus Low-Voltage Areas ablation during sinus rhythm Versus. CPVI Plus Low-Voltage Areas Ablation During AF and CPVI alone.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 7 Jul 2024
- Start date
- 15 Jul 2024
- Primary completion date
- 15 Jul 2026
- Lead sponsor
- Yantai Yuhuangding Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06499818
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 15 Jul 2024 to the primary completion date, 15 Jul 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who had previously undergone atrial fibrillation, atrial tachycardia, or atypical atrial flutter ablation
Other illness
- Postoperative cardiac surgery
- Patients with moderate-to-severe aortic valve disease, moderate-to-severe mitral stenosis, and severe other valvular disease
- Hemorrhagic stroke within 6 months
- Transient ischemic attack or ischemic stroke within 1 month
- Mental disorder or history of mental illness and inability to cooperate voluntarily
Lab values
- Left ventricular ejection fraction \<35%
Other
- Preoperative combined atrial tachycardia (≥30S) and atypical atrial flutter
- Left atrial diameter \>55mm
- Left atrial thrombus
- After valve replacement
- After permanent pacemaker implantation
- hypertrophic cardiomyopathy
- Breastfeeding, pregnancy and women planning or likely to become pregnant
- Life expectancy \<12 months
- Participating in other interventional clinical trials
- The researchers judged that it was not suitable for inclusion in this study
Who the study is looking for
- Patients age is 18-80 years;
- Patients with non-paroxysmal AF; non-paroxysmal AF will be defined as a sustained episode lasting \> 7 days;
- Patients can sign the written informed consent for the study;
- Patients can endure the required follow-up.
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.